Skip to content

Clinical study on the treatment of Rhegmatogenous Retinal Detachment by folding Foldable Capsular Buckle sclera external top pressure

Clinical study on the treatment of Rhegmatogenous Retinal Detachment by folding Foldable Capsular Buckle sclera external top pressure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038224
Enrollment
Unknown
Registered
2020-09-14
Start date
2020-09-15
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhegmatogenous Retinal Detachment

Interventions

Group FCB:Foldable Capsular Buckle sclera external top pressure
Group silicone:Silica gel is pressurized outside the sclera

Sponsors

The First People's Hospital of Xuzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Volunteer to participate in the researcher 2) No limitation for men or women over the age of 18; 3) Conform to RRD(within one quadrant & LT;2 single hiatus or < of PD;3. Diagnostic criteria for adjacent multiple holes of PD, below grade PVR-B); 4) Intraocular axial length 26 mm(myopia degree & LT;600 degrees); 5) With good general condition and no contraindications for operation; 6) Be able to understand the purpose of the study, voluntarily participate in and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Endophthalmitis; 2) The holes are flanged and pulled;Large or dispersed vitreous traction, fixed retinal folds 3) ABOVE GRADE PVR-C; 4) Other accompanying ophthalmic diseases that cannot be controlled, such as glaucoma, cataract above tertiary nucleus and macular disease; 5) Previous history of eye surgery and trauma; 6) Patients with known silica gel allergy and scar constitution; In addition to 1) Patients participating in other clinical trials; 2) Other reasons were not considered appropriate by the researchers for clinical trials.

Design outcomes

Primary

MeasureTime frame
Retinal reduction rate;

Secondary

MeasureTime frame
Ocular surface conditionOcular surface condition;diopter;

Countries

China

Contacts

Public ContactLi Suyan

The First People's Hospital of Xuzhou

lisuyan1226@126.com+86 13852101775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026